Clinical trial
Testosterone in Treating Patients With Progressive Prostate Cancer That No…
NCT00006044 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006044 |
|---|---|
| Title | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy |
| Official title | A Phase I Trial of Testosterone in Patients With Progressive Androgen-Independent Prostate Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | therapeutic testosterone |
| Start date | Feb 1, 2000 |
| Primary completion | Feb 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: